 Clarus Therapeutics Holdings Inc NASDAQ: CRXT shares are trading lower by 52.82 at 0.85 after the company announced an upsized 30 million underwritten public offering at 1.10 per share. The offering is expected to close on April 27, 2022, subject to customary closing conditions. 